BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 31 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,347,549 | -1.6% | 14,450,000 | 0.0% | 0.02% | -9.1% |
| Q2 2023 | $14,574,848 | -3.0% | 14,450,000 | 0.0% | 0.02% | -12.0% |
| Q1 2023 | $15,023,954 | +1.5% | 14,450,000 | +5.5% | 0.02% | -3.8% |
| Q4 2022 | $14,808,741 | +8.8% | 13,700,000 | 0.0% | 0.03% | 0.0% |
| Q3 2022 | $13,605,000 | +14.1% | 13,700,000 | +14.2% | 0.03% | +23.8% |
| Q2 2022 | $11,926,000 | -0.7% | 12,000,000 | 0.0% | 0.02% | +16.7% |
| Q1 2022 | $12,005,000 | -26.5% | 12,000,000 | -23.6% | 0.02% | -21.7% |
| Q4 2021 | $16,340,000 | +5.1% | 15,700,000 | 0.0% | 0.02% | -8.0% |
| Q3 2021 | $15,546,000 | -1.2% | 15,700,000 | 0.0% | 0.02% | -3.8% |
| Q2 2021 | $15,731,000 | – | 15,700,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 30,062 | $30,276,000 | 2.06% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 45,103,000 | $45,311,000 | 0.72% |
| MACKAY SHIELDS LLC | 76,920,000 | $77,403,000 | 0.68% |
| LOOMIS SAYLES & CO L P | 2,277,794 | $175,618,000 | 0.24% |
| KBC Group NV | 300,000 | $30,339,000 | 0.11% |
| CAMDEN ASSET MANAGEMENT L P /CA | 3,200,000 | $3,204,000 | 0.10% |
| Allianz Asset Management GmbH | 116,770,000 | $118,163,000 | 0.09% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,143,000 | $3,168,000 | 0.07% |
| Lombard Odier Asset Management (Europe) Ltd | 1,600,000 | $1,610,000 | 0.06% |
| THRIVENT FINANCIAL FOR LUTHERANS | 16,400,000 | $16,421,000 | 0.03% |